Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies (TTI-622-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03530683
Recruitment Status : Recruiting
First Posted : May 21, 2018
Last Update Posted : July 15, 2021
Sponsor:
Information provided by (Responsible Party):
Trillium Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 30, 2022
Estimated Study Completion Date : December 30, 2022